Last reviewed · How we verify
SULFADIAZINE SODIUM
At a glance
| Generic name | SULFADIAZINE SODIUM |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1941 |
Approved indications
Common side effects
Key clinical trials
- Clinical Investigation to Evaluate the Safety and Performance of ConnettivinaBio Plus Cream Compared to ConnettivinaBio Cream in the Management of Wounds in Patients at High Risk of Infection (NA)
- Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group (PHASE4)
- Comparative Evaluation of Two AQUACEL Ag Protocols of Care for the Management of Donor Sites (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SULFADIAZINE SODIUM CI brief — competitive landscape report
- SULFADIAZINE SODIUM updates RSS · CI watch RSS